San Francisco Bay Area Drug Trends and Effective Intervention Strategies Alice Gleghorn, Ph.D County Alcohol and Drug Program Administrator San Francisco.

Slides:



Advertisements
Similar presentations
Daliah Heller, PhD, MPH Assistant Commissioner
Advertisements

Sharon Stancliff, MD Caroline Rath, PA-C Harm Reduction Coalition New York, NY USA.
John R. Kasich, Governor Orman Hall, Director 1. John R. Kasich, Governor Orman Hall, Director 2  Tolerance  Euphoria  Withdrawal.
Project Lazarus/CCNC A statewide initiative to prevent drug overdose Dr. Robin Gary Cummings Deputy Secretary for Health Services State Health Director.
Models of Harm Reduction
National Institute on Drug Abuse P rescription D rug A buse: An Escalating Public Health Threat P rescription D rug A buse: An Escalating Public Health.
Project Coordinator Overdose Prevention Project, Prevention Point Pittsburgh Alice Bell, LCSW.
Findings from the Drug Abuse Warning Network Narcotic Analgesics Judy K. Ball, Ph.D., M.P.A. Office of Applied Studies, Substance Abuse and Mental Health.
Opioid Safety Phillip Coffin, MD, MIA Director of Substance Use Research San Francisco Dept. of Public Health Assistant Clinical Professor University of.
TM Centers for Disease Control and Prevention National Center for Injury Prevention and Control Centers for Disease Control and Prevention National Center.
Drug Trends in Washington State & King County Caleb J. Banta-Green MPH MSW Alcohol & Drug Abuse Institute University of Washington
Prescription Opioids: Extramedical Use and Overdose
John R. Kasich, Governor Tracy J. Plouck, Director Andrea Boxill, Deputy Director Andrea Boxill, Deputy Director Governor’s Cabinet Opiate Action Team.
P RESCRIPTION D RUG A BUSE : T HE N ATIONAL P OLICY P ERSPECTIVE Michael Gottlieb, National HIDTA Director Office of National Drug Control Policy May 7,
Methadone in Opioid Addiction David Kan, M.D. University of California San Francisco VA Medical Center San Francisco.
Prescription Opioid Use and Opioid-Related Overdose Death — TN, 2009–2010 Jane A.G. Baumblatt, MD Centers for Disease Control and Prevention Epidemic Intelligence.
The South Florida Report January 2013 National Institute on Drug Abuse Community Epidemiology Work Group James N. Hall Report # 56 Center for Applied Research.
FUNDING OPPORTUNITIES. BACKGROUND New category of funding in the FY13 Harold Rogers Prescription Drug Monitoring Program Official title is “Category 3:
Implementation in Ohio’s Regional Psychiatric Hospitals.
The National Strategy for Suicide Prevention: Everyone Has a Role Richard McKeon Ph.D.
Overview of Harm Reduction and Sterile Syringe Access Anna Benyo Syringe Access Policy Coordinator Harm Reduction Coalition New Jersey Syringe Access Informational.
1 Mental Health and Substance Abuse Services Division Association of Substance Abuse Providers Mike Maples October 5, 2011.
Mental Health and Substance Abuse Services Joe Vesowate Assistant Commissioner.
Recommendations on the Management of Opioid Overdose Ruth Birgin.
John R. Kasich, Governor Tracy J. Plouck, Director Andrea Boxill, MA Deputy Director 1.
John R. Kasich, Governor Tracy J. Plouck, Director Andrea Boxill, MA Deputy Director 2/23/20151.
Rx for Success Next Steps to Prevent Prescription Drug Abuse Rebecca Hebner, MPH Substance Abuse Prevention Systems Coordinator.
March 2004 Prescription Drug Abuse in the United States.
Saves Lives Oklahoma’s Plan to Reduce Prescription Drug Abuse and Prevent Overdose.
1. 2 National Institute on Drug Abuse Community Epidemiology Work Group (CEWG) Established 1976.
1 Alcohol and Substance Abuse Council of Jefferson County, Inc. 167 Polk Street, Suite 320 Watertown, New York Voice: ; Fax: ;
Theodore M. Hammett, Ph.D. Sofia Kennedy, M.P.H. Drug Abuse and Risky Behaviors: The Evolving Dynamics of HIV/AIDS NIH-Bethesda, MD May 9, 2007 HIV/AIDS.
Addressing Substance Use Disorders Translating Science To Policy In The 2010 Drug Control Strategy.
Quaboag Hills Community Coalition Substance Use Task Force October 20, 2014 Overview of the Strategic Prevention Framework (SPF) “Road Map” What are Evidence-Based.
An integrated approach to addressing opiate abuse in Maine Debra L. Brucker, MPA, PhD State of Maine Office of Substance Abuse October 2009.
Drug Abuse Trends in the State of California Presented to: CA Association for Criminal Justice Research March 17, 2005 Presented by: Kiku Annon, MA, WestEd.
A Profile of Women in Treatment in California Data from the California Outcome Measurement System January – December 2006.
Broward County Report Substance Abuse Issues and Trends – Winter 2013 James N. Hall.
MBEMSC /PIER Committee
OVERDOSE SOLUTIONS 2013 SAFE LANDING AN ACOPC INITIATIVE Tami Slain, RN.
Pennsylvania: The State of HCV 2015
SOURCE: Treatment Episode Data Set (TEDS) 2005SOURCE: Treatment Episode Data Set (TEDS) 2005 Admissions to Substance Abuse Treatment for the Abuse of Opioid.
Maryland’s “Good Samaritan” Law Annotated Code of Maryland, Criminal Procedure §1-210 Effective October 1, 2015 September
Heroin Associated Deaths in Greene County, Ohio Jane McClelland, BSN, RN, Public Health Nurse Melissa Howell, Health Commissioner Don Brannen, PhD, MHSA,
State of the State in outcomes: Prescription drug overdoses Karin A. Mack, PhD Senior Behavioral Scientist Prescription Drug Overdose Team National Center.
Opiate Management Douglas Keehn DO Adjunct Assistant Clinical Professor University Wisconsin Board Certified Anesthesia & Pain Management.
1 December 8, 2015 Crista M. Taylor, LCSW-C Director, Information, Planning and Development Adrienne Breidenstine, MSW Director of Opioid Overdose Prevention.
Jennifer R. Havens, PhD, MPH Associate Professor
DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration OFFICE OF APPLIED STUDIES Treatment Episode Data Set.
Prevention, Identification and Treatment of Opioid Use Disorders: A Personal Perspective Leah Bauer, MD Medical Director, Addiction Resource Center, Mid.
1 READY BY 21 TASKFORCE Harford County Department of Community Services Local Management Board Health Benchmark December 7, 2010.
Bystander Naloxone Training Saves Lives. Death rates are spiraling out of control--for both prescription opioids and heroin! Graphic: Nytimes.com.
Overdose Prevention Pilot Project Cross Systems Collaboration. Naloxone Distribution In cooperation with LA Community Health Project June 4, 2014, VCBH,
Substance Use Disorders and Overdose: The Basics Public Curricula – Essential Knowledge for Families and Communities Core Component.
Findings from the Drug Abuse Warning Network Immediate and Sustained Release Opioid Analgesics Judy K. Ball, Ph.D., M.P.A. Office of Applied Studies, Substance.
State Targeted Response to Opioid Crisis
10th Annual Susan Li Conference
Cabarrus County Substance Abuse
Experiences from a national overdose prevention strategy: Nasal naloxone distribution and lessons learned Philipp Lobmaier, MD, PhD Norwegian Centre.
Steve Alsum The Grand Rapids Red Project
A State Targeted Response to the Opioid Crisis:
Primary Prevention in the Time of the Opioid Epidemic
Evaluation of California’s Hub and Spoke System
Opiate Roundtable March 29, 2018 Karen Burgess, MD
Other Illicit Drug Use in Delaware: 2018 State Epidemiological Profile
2018 Delaware State Epidemiological Profile
2018 Delaware State Epidemiological Profile
Naloxone in North Carolina
Human Dignity and Harm Reduction
Medically assisted treatment
Presentation transcript:

San Francisco Bay Area Drug Trends and Effective Intervention Strategies Alice Gleghorn, Ph.D County Alcohol and Drug Program Administrator San Francisco Department Of Public Health

HEROIN PRICE* AND PURITY *Price unit = per milligram pure 2001 $1.4010% 2002 $0.9912% 2003 $0.9811% 2004 $0.9811% 2005 $0.8912% 2006 $0.6910% 2007 $1.28 8% 2008 $ % 2009 $ % 2010 $ % 2011 $ % Source: DEA 2011 Heroin DMP, March 2011

Lab analysis of “Gunpowder” sample in 2012 found heroin, lidocaine, codeine, and morphine

San Francisco ED Reports Source: DAWN 2011(weighted data) Drugs Heroin 2,4243,1381,9941,9931,6161,2241, Opiates/opioids 1,0552,1721,7031,3691,7842,0432,4742,614 -Opiates,unspec NarcoticAnalges 8391,8041,3321,1521,5041,6491,8631, Buprenorphine/ ******** ---Codeine/combo 69******* ---Fentanyl/combo *****124* Hydrocodone/co Hydromorphone *****141* Methadone Morphine/comb Oxycodone/co

San Francisco ED Reports , % change Source: DAWN 2011 Percent Change (p < 0.05) vs vs vs Heroin2,4241, Opiates 1,0552,4742, Opiates, unspec Narcotic analges 8391,8631, Fentanyl/comb **171 --Hydrocodone/co Hydromorphone/ **180 --Methadone Morphine/comb Oxycodone/comb Drug Abuse Warning Network, 2011: Selected Tables of National Estimates of Drug-Related Emergency Department Visits. Rockville, MD: Center for Behavioral Health Statistics and Quality, SAMHSA, 2013

5 Bay Area Counties: 2012 Prescription Quantities By Drug Name

5 Bay Area Counties: Prescription Quantities Hydrocodone/APAP CURES Data provided by Mike Small, CA DOJ

Primary Drug Treatment Problem: Percent of total admissions 5 Bay Area Counties; FY Source: DHCS CalOMS Data System, Craig Chaffee

San Francisco Treatment Service Episode by Primary Drug Problem : FY0607 through FY1112 (Source: CBHS BIS Admission Data)

SAN FRANCISCO COUNTY PRIMARY DRUG AT TREATMENT ADMISSION PERCENTAGE BY AGE, [I] [I] [i] [i] Source: CalOMS Tx Data, Department of Alcohol and Drug Programs

1997: Treatment On Demand Treatment Expansion: Significant, sustained local funding increase Commitment to Harm Reduction approach: Reaching people wherever they are to reduce death and drug-related harm “Heroin Issues” subcommittee: –1. Hep C Prevention –2. Alternative Treatment modalities –3. Soft-Tissue Infection –4. OVERDOSE DEATH PREVENTION

TOD Heroin Issues Committee Actions: 1) Train Community Outreach & Syringe Exchange on overdose prevention education 2) Conduct broad public education campaign to increase overdose awareness 3) Target overdose response training for people at-risk of heroin overdose in jails, probation, and drug treatment programs 4) Test the feasibility and effectiveness of training heroin users to administer naloxone as an overdose death prevention tool

Drug Overdose Prevention Education (DOPE) Focus Overdose Risk Factors Recognizing Overdose signs Overdose response: –Call 911, Rescue Breathing, Recovery Position,& Follow Up Medical care Naloxone Pilot Program –2003- Naloxone distribution and refills 2010 – Intra-Nasal device Target populations –SROs, Jail, SEPs, –Residential and Opiate Treatment Programs –AB 109 (Prisoners released to communities) –Pharmacy/Primary Care, Pain medication

Deaths Involving Drug Abuse – DAWN SF Metropolitan Area Source: Office of Applied Studies, SAMHSA, Drug Abuse Warning Network, 2002 ( update) Heroin deaths: 1997= 297; 2010= 8